Role of Murine Leukemia Virus Reverse Transcriptase Deoxyribonucleoside Triphosphate-Binding Site in Retroviral Replication and In Vivo Fidelity
暂无分享,去创建一个
Evguenia S. Svarovskaia | V. Pathak | E. Svarovskaia | Vinay K. Pathak | Elias K. Halvas | E. Halvas
[1] Miguel Ángel Martínez,et al. Mutational analysis of Phe160 within the "palm" subdomain of human immunodeficiency virus type 1 reverse transcriptase. , 1999, Journal of molecular biology.
[2] P. Charneau,et al. A highly defective HIV-1 group O provirus: evidence for the role of local sequence determinants in G-->A hypermutation during negative-strand viral DNA synthesis. , 1995, Virology.
[3] B. Larder,et al. Mutational analysis of two conserved sequence motifs in HIV‐1 reverse transcriptase , 1991, FEBS letters.
[4] Jianping Ding,et al. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. , 1994, Journal of molecular biology.
[5] L. Loeb,et al. Human Immunodeficiency Virus Reverse Transcriptase , 1996, The Journal of Biological Chemistry.
[6] W. C. Drosopoulos,et al. Increased polymerase fidelity of E89G, a nucleoside analog-resistant variant of human immunodeficiency virus type 1 reverse transcriptase , 1996, Journal of virology.
[7] L. Loeb,et al. Fidelity of mutant HIV-1 reverse transcriptases: interaction with the single-stranded template influences the accuracy of DNA synthesis. , 1998, Biochemistry.
[8] M. Modak,et al. Elucidation of the role of Arg 110 of murine leukemia virus reverse transcriptase in the catalytic mechanism: biochemical characterization of its mutant enzymes. , 1996, Biochemistry.
[9] M. Wainberg,et al. Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[11] S. Goff,et al. Replication Defect of Moloney Murine Leukemia Virus with a Mutant Reverse Transcriptase That Can Incorporate Ribonucleotides and Deoxyribonucleotides , 1998, Journal of Virology.
[12] M. Bakhanashvili,et al. Mutational studies of human immunodeficiency virus type 1 reverse transcriptase : the involvement of residues 183 and 184 in the fidelity of DNA synthesis , 1996, FEBS letters.
[13] M. Tisdale,et al. Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89 , 1997, Antimicrobial agents and chemotherapy.
[14] V. Pathak,et al. Development of an In Vivo Assay To Identify Structural Determinants in Murine Leukemia Virus Reverse Transcriptase Important for Fidelity , 2000, Journal of Virology.
[15] J. Coffin,et al. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.
[16] S. Montaño,et al. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain. , 2000, Journal of molecular biology.
[17] W A Hendrickson,et al. Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Wainberg,et al. Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse Transcriptase , 1996, Science.
[19] V. Pandey,et al. Functional Analysis of Amino Acid Residues Constituting the dNTP Binding Pocket of HIV-1 Reverse Transcriptase* , 1998, The Journal of Biological Chemistry.
[20] V. Pathak,et al. Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication , 1996, Journal of virology.
[21] K Bebenek,et al. The accuracy of reverse transcriptase from HIV-1. , 1988, Science.
[22] S. Sarafianos,et al. Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase. , 1995, Biochemistry.
[23] H. Temin,et al. Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Merigan,et al. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy , 1996, Journal of virology.
[25] A. D. Clark,et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[26] I Sauvaget,et al. Identification of four conserved motifs among the RNA‐dependent polymerase encoding elements. , 1989, The EMBO journal.
[27] D. Littman,et al. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range , 1991, Journal of virology.
[28] B. Chesebro,et al. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. , 1983, Virology.
[29] A. Miller,et al. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production , 1986, Molecular and cellular biology.
[30] Samuel H. Wilson,et al. Vertical-scanning Mutagenesis of a Critical Tryptophan in the Minor Groove Binding Track of HIV-1 Reverse Transcriptase , 1998, The Journal of Biological Chemistry.
[31] E. De Clercq,et al. Anti-Human Immunodeficiency Virus Drug Combination Strategies , 1998, Antiviral chemistry & chemotherapy.
[32] T. Darden,et al. Reduced Frameshift Fidelity and Processivity of HIV-1 Reverse Transcriptase Mutants Containing Alanine Substitutions in Helix H of the Thumb Subdomain (*) , 1995, The Journal of Biological Chemistry.
[33] E. Domingo,et al. Mispair extension fidelity of human immunodeficiency virus type 1 reverse transcriptases with amino acid substitutions affecting Tyr115. , 1997, Nucleic acids research.
[34] G. Saunders,et al. Salt-induced structural changes in nucleosomes. , 1977, Nucleic acids research.
[35] M A Wainberg,et al. Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine , 1994, Antimicrobial Agents and Chemotherapy.
[36] Brendan A. Larder,et al. Site-specific mutagenesis of AIDS virus reverse transcriptase , 1987, Nature.
[37] H. Mitsuya,et al. Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistant to Multiple 2′,3′-Dideoxynucleoside 5′-Triphosphates (*) , 1995, The Journal of Biological Chemistry.
[38] V. Pathak,et al. The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate , 1997, Journal of virology.
[39] S. Sarafianos,et al. Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Ortín,et al. Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. , 1986, Nucleic acids research.
[41] E. Wimmer,et al. A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation , 1988, Journal of virology.
[42] G L Verdine,et al. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. , 1998, Science.
[43] G. Gerard,et al. Substrate binding domain of murine leukemia virus reverse transcriptase. Identification of lysine 103 and lysine 421 as binding site residues. , 1988, The Journal of biological chemistry.
[44] V. Pathak,et al. E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy , 1995, Journal of virology.
[45] E. Domingo,et al. Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis. , 1996, The EMBO journal.
[46] A. D. Clark,et al. Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms. , 1996, Structure.
[47] W A Hendrickson,et al. Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. , 1995, Structure.
[48] N. Rege,et al. Role of glutamine-151 of human immunodeficiency virus type-1 reverse transcriptase in RNA-directed DNA synthesis. , 1997, Biochemistry.
[49] D. Housman,et al. Ouabain resistance conferred by expression of the cDNA for a murine Na+, K+-ATPase alpha subunit. , 1987, Science.
[50] K. Singh,et al. Analysis of the Role of Glutamine 190 in the Catalytic Mechanism of Murine Leukemia Virus Reverse Transcriptase* , 1999, The Journal of Biological Chemistry.
[51] S. Sarafianos,et al. Site-directed Mutagenesis of Arginine 72 of HIV-1 Reverse Transcriptase , 1995, The Journal of Biological Chemistry.